Live Poll Results — Which of these medical product innovations was first approved as a dual GIP/GLP-
See real-time poll results. Powered by AIPolls.Net.
Medical Product Innovation Breakthrough
The healthcare industry is constantly evolving with innovative products that revolutionize patient care. This poll tests your knowledge about a significant recent breakthrough in medical product innovation that has transformed treatment approaches for a common chronic condition. Understanding these innovations helps healthcare professionals stay informed about cutting-edge options for their patients.
Which of these medical product innovations was first approved as a dual GIP/GLP-1 receptor agonist, creating a new category in diabetes and obesity treatment?
Poll Type: Trivia | Total Votes: 0
| Option | Votes | Percentage |
|---|---|---|
| {'choice_text': 'Tirzepatide (Mounjaro/Zepbound)', 'is_correct': True} | 0 | 0% |
| {'choice_text': 'Semaglutide (Ozempic/Wegovy)', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Liraglutide (Saxenda/Victoza)', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Dulaglutide (Trulicity)', 'is_correct': False} | 0 | 0% |